SEC Form 4Coverage since Jun 8, 2026
$IPSC insider trading
Over the last 12 months, Century Therapeutics insiders reported no purchases and 5 sales totaling $12K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $12K 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $IPSC · 12Mvia TradingView
Top insiders · 12m
Carr DouglasSVP Finance & Operations3× · $5K
Russotti GregorySee Remarks2× · $7K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 275 | $1.98 | $544 | -0.1% | — |
| Jun 12, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 2,584 | $2.23 | $6K | -0.5% | — |
| Jun 12, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 1,654 | $2.23 | $4K | -0.3% | — |
| Jun 8, 2026 | Russotti GregorySee Remarks · O | ▼ Sale | 524 | $2.11 | $1K | -0.1% | — |
| Jun 8, 2026 | Carr DouglasSVP Finance & Operations · O | ▼ Sale | 249 | $2.11 | $526 | — | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IPSC feed.